在新生儿中使用抗生素的药理动力学和药理动力学考虑
Mario Regazzi1, Alberto Berardi2, Simonetta Picone3
1S.I.F.E.B, Italian Society of Pharmacokinetics and Biopharmaceutics, 27100 Pavia, Italy.
Antibiotics (Basel, Switzerland)
|December 23, 2023
概括
优化新生儿抗生素剂量需要了解药物特性和器官发育. 基于模型的精确剂量,使用贝叶斯预测,有助于量身定制抗生素治疗,以获得新生儿更好的结果.
科学领域:
- 新生儿药理学 新生儿药理学
- 临床药理动力学 临床药理动力学
- 抗生素管理的管理.
背景情况:
- 新生儿的抗生素剂量是复杂的,因为影响药物分发和清除的器官系统正在发育.
- 标准剂量可能无法在新生儿中达到最佳的药理动力学/药理动力学 (PK/PD) 目标.
- 对新生儿抗生素治疗的先进剂量策略越来越感兴趣.
研究的目的:
- 突出PK/PD特性在新生儿抗生素剂量中的重要性.
- 讨论新生儿替代抗生素剂量策略.
- 强调基于模型的精确剂量在优化新生儿抗生素暴露中的作用.
主要方法:
- 对新生儿相关的药理动力学和药理动力学原则的审查.
- 讨论替代剂量策略,包括最小抑制度 (MIC) 和治疗药物监测 (TDM).
- 探索基于模型的精确剂量,特别是贝叶斯预测软件.
主要成果:
- 新生儿器官发育显著影响药物PK/PD,需要量身定制的剂量.
- 当与MIC和TDM相结合时,替代剂量策略可以提高抗生素的成功率.
- 贝叶斯预测提供了一种优化新生儿群体抗生素暴露的方法.
结论:
- 优化新生儿抗生素治疗需要深入了解PK/PD和个体患者的因素.
- 基于模型的精确剂量,像贝叶斯预测一样,是个性化新生儿抗生素治疗的宝贵工具.
- 有效的新生儿抗生素优化需要临床医生,实验室技术人员和定量药理学家之间的跨学科合作.
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Factors Affecting Drug Distribution: Miscellaneous Factors
343
Drug distribution in the human body is a complex process influenced by various individual factors, including age, pregnancy, obesity, diet, body water composition, pH levels, and specific disease conditions.
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
Age plays a significant role due to differences in body composition among different age groups. Infants, for instance, have a higher proportion of total body water and lower albumin levels, a protein that binds drugs in the bloodstream. This unique composition in infants enhances the...
343
Factors Affecting Protein-Drug Binding: Patient-Related Factors
61
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
61
Nonlinear Pharmacokinetics: Overview
385
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
385
Nonlinear Pharmacokinetics: Role of Transporters
52
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
52
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
152
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
152


